跳至主要内容
临床试验/JPRN-UMIN000011825
JPRN-UMIN000011825已完成未知

Study on the clinical significance of Saireito in patients with hypertensive nephropathy - Clinical effects of Saireito in patients with hypertensive nephropathy

ational Center for Global Health and Medicine0 个研究点目标入组 20 人开始时间: 2013年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • * in pregnancy and lactating * contraindicative or impossible to use for some reason for Saireito * treated with oral corticosteroids or immunosuppressant therapy * interstitial pneumonitis * definite diabetes mellitus * marked renal impairment (eGFR = or < 30 ml/min) * primary renal disease * secondary renal disease * serious CHF * serious arrythmia * within 6 months after AMI * within 6 months after cerebrovascular disease

研究者

发起方
ational Center for Global Health and Medicine

相似试验